Global Pipeline Review & Analysis of Hematological Malignancies Report Available Now.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c53926) has announced the addition of "Global Pipeline Review & Analysis of Hematological Malignancies Although hematological malignancies are a form of cancer, they are generally treated by specialists in hematology, although in many hospitals oncology specialists also manage these diseases. " to their offering. Introduction The markets segments for therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. for hematological malignancies are numerous and complicated. The historical general conception that relatively low prevalence diseases, has been insufficient in size to allow companies to quickly regain their investment is clearly out of date. In this perspective enhanced development is expected. Among the emerging therapeutic strategies, passive and active immunotherapies active immunotherapy The administration of substances to evoke a protective immune response in the form of specific antibodies. Cf Passive immunotherapy, Vaccine. have clearly continued to be leading strategies. Small molecule apoptotic inducers and kinase kinase /ki·nase/ (ki´nas) 1. a subclass of the transferases, comprising the enzymes that catalyze the transfer of a high-energy group from a donor (usually ATP) to an acceptor. 2. inhibitors are as well in the forefront. About this report In this unique report, Global Pipeline Review & Analysis of Hematological Malignancies, the author reports on the hematological hematological, hematologic pertaining to or emanating from blood cells. hematological tests total and differential white cell counts, hematocrit estimation, erythrocyte count. cancer pipeline by: Investigator - Includes 212 investigators and partners Drug - Includes 237 "active" drugs Sub-indication - Includes 11 sub-indications Developmental stage - Includes 8 developmental stages Compound type - Includes 21 different compounds types Targeted therapy strategy - Includes 5 different targeted therapy strategies Target - Includes 97 different protein targets Signaling pathway pathway /path·way/ (path´wa) 1. a course usually followed. 2. the nerve structures through which an impulse passes between groups of nerve cells or between the central nervous system and an organ or muscle. - Includes 18 different signaling pathways All of above "factors" are cross referenced against each other, generating highly valuable insights in 40 figures and 53 tables. Read more below about each "factor" included in this cutting edge analysis. Investigator This report includes 212 investigators and partners from all over the world. Topics Covered: -Players in the field of hematological malignancies -The hematological cancer drug pipeline -Protein targets in hematological cancers -Compounds -Targeted therapies in hematological cancers -Targeted therapy strategies versus compound types in hematological cancers -Pursued signaling pathways in hematological cancers -Brief drug description For more information, visit http://www.researchandmarkets.com/reports/c53926. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion